Home Topics

HIV/AIDS

NEW & NOTEWORTHY

ending the hiv epidemic (ehe) initiative

Ending the HIV Epidemic Funding Tracker

This tracker provides up-to-date data on federal Ending the HIV Epidemic (EHE) funding, including an overview of funding mechanisms by year, agency, grant mechanism, and jurisdiction.

HIV in the U.S.

The U.S. HIV/AIDS Epidemic

This fact sheet provides the latest data on the U.S. HIV epidemic, including key trends over time, impact by region and population, and information on the U.S. government’s response.

HIV Testing in the United States

This fact sheet provides information on key HIV testing statistics, testing recommendations, insurance coverage of HIV testing, testing sites and policies, and types of tests available.

The Ryan White Program

This fact sheet provides an overview of the Ryan White HIV/AIDS Program, the largest HIV-specific federal grant program in the United States.

Greater Than

These accessible, mobile-friendly resources include more than 100 FAQs, in both English and Spanish, covering HIV and STD basics, testing, prevention and treatment. Greater Than can also help you find free and low cost testing near you. 

 

global hiv/aids epidemic

PEPFAR Policy Resource Hub

This hub brings together key U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) policy resources – from KFF, the U.S. government, and others – that can be used to inform policy discussions and research. More items will be added to the hub over time.

The Global HIV/AIDS Epidemic

This updated fact sheet provides the latest data on the global HIV/AIDS epidemic, including impact on affected and vulnerable populations, treatment and prevention efforts, and an overview of the U.S. and global responses to the epidemic.

Global HIV/AIDS Timeline

The Global HIV/AIDS Timeline is an ongoing reference tool for the many political, scientific, cultural, and community developments that have occurred over the history of the HIV/AIDS epidemic.

Latest News

More KFF Health News

Subscribe to KFF Emails

Choose which emails are best for you.
Sign up here

View the Latest: HIV/AIDS

Filter

List Grid

1 - 10 of 691 Results

  • Assessing PEPFAR’s Health Spillover Effects Beyond HIV: An Update

    Issue Brief

    This analysis updates prior work that assessed the association between PEPFAR investments and several health indicators, beyond HIV. It finds that PEPFAR continues to be associated with significant improvement in these broader health gains, suggesting a spillover effect beyond the program's HIV focus.

  • Assessing PEPFAR’s Economic and Educational Spillover Effects: An Update

    Issue Brief

    This analysis updates prior work that assessed the association between PEPFAR investments and economic and educational outcomes. It finds that PEPFAR continues to be associated with significant improvement in these broader areas, suggesting a spillover effect beyond the program's HIV and health focus.

  • U.S. Global Health Budget Tracker

    Feature

    This tracker provides regularly updated information on U.S. government funding for global health. It includes historical trends and tracks funding levels for U.S. global health efforts through bilateral and multilateral contributions and by program area and agency.

  • The Global HIV/AIDS Epidemic

    Fact Sheet

    This updated fact sheet provides the latest data on the global HIV/AIDS epidemic, including impact on affected and vulnerable populations, treatment and prevention efforts, and an overview of the U.S. and global responses to the epidemic.

  • Constrained Budgets Lead States to Restrict HIV Drug Access Through Ryan White

    Policy Watch

    States are facing constrained budgets, putting pressure on HIV programs, including the Ryan White HIV/AIDS Program. This Policy Watch explores how state Ryan White AIDS Drug Assistance Programs (ADAPs) are responding to these budget pressures, including by restricting eligibility and reducing the scope of services offered, actions that could led to negative health outcomes for people with HIV and lead to new HIV infections.